<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Baber U</submitter><funding>NHLBI NIH HHS</funding><funding>NINDS NIH HHS</funding><pagination>373-380.e2</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC4139360</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>166(2)</volume><pubmed_abstract>&lt;h4>Background&lt;/h4>Lipid-lowering guidelines endorse a low-density lipoprotein cholesterol goal of &lt;100 mg/dL for people with coronary heart disease (CHD). A more stringent threshold of &lt;70 mg/dL is recommended for those with CHD and "very high-risk" conditions such as diabetes mellitus, metabolic syndrome, or cigarette smoking. Whether chronic kidney disease (CKD) confers a similar risk for recurrent CHD events is unknown.&lt;h4>Methods and results&lt;/h4>We evaluated the risk for recurrent CHD events and all-cause mortality among 3,938 participants ≥45 years with CHD in the Reasons for Geographic and Racial Differences in Stroke (REGARDS) study. Chronic kidney disease was defined by estimated glomerular filtration rate &lt;60 mL/min per 1.73 m(2) or urinary albumin to creatinine ratio ≥30 mg/g. P</pubmed_abstract><journal>American heart journal</journal><pubmed_title>Risk for recurrent coronary heart disease and all-cause mortality among individuals with chronic kidney disease compared with diabetes mellitus, metabolic syndrome, and cigarette smokers.</pubmed_title><pmcid>PMC4139360</pmcid><funding_grant_id>U01 NS041588</funding_grant_id><funding_grant_id>U01NS041588</funding_grant_id><funding_grant_id>R01 HL080477</funding_grant_id><pubmed_authors>Baber U</pubmed_authors><pubmed_authors>Muntner P</pubmed_authors><pubmed_authors>Safford MM</pubmed_authors><pubmed_authors>Farkouh ME</pubmed_authors><pubmed_authors>Tonelli M</pubmed_authors><pubmed_authors>Gutierrez OM</pubmed_authors><pubmed_authors>Warnock DG</pubmed_authors><pubmed_authors>Levitan EB</pubmed_authors></additional><is_claimable>false</is_claimable><name>Risk for recurrent coronary heart disease and all-cause mortality among individuals with chronic kidney disease compared with diabetes mellitus, metabolic syndrome, and cigarette smokers.</name><description>&lt;h4>Background&lt;/h4>Lipid-lowering guidelines endorse a low-density lipoprotein cholesterol goal of &lt;100 mg/dL for people with coronary heart disease (CHD). A more stringent threshold of &lt;70 mg/dL is recommended for those with CHD and "very high-risk" conditions such as diabetes mellitus, metabolic syndrome, or cigarette smoking. Whether chronic kidney disease (CKD) confers a similar risk for recurrent CHD events is unknown.&lt;h4>Methods and results&lt;/h4>We evaluated the risk for recurrent CHD events and all-cause mortality among 3,938 participants ≥45 years with CHD in the Reasons for Geographic and Racial Differences in Stroke (REGARDS) study. Chronic kidney disease was defined by estimated glomerular filtration rate &lt;60 mL/min per 1.73 m(2) or urinary albumin to creatinine ratio ≥30 mg/g. P</description><dates><release>2013-01-01T00:00:00Z</release><publication>2013 Aug</publication><modification>2025-04-18T21:46:16.43Z</modification><creation>2019-03-27T01:34:25Z</creation></dates><accession>S-EPMC4139360</accession><cross_references><pubmed>23895822</pubmed><doi>10.1016/j.ahj.2013.05.008</doi></cross_references></HashMap>